Journal
MOLECULAR CANCER RESEARCH
Volume 3, Issue 2, Pages 90-99Publisher
AMER ASSOC CANCER RESEARCH
DOI: 10.1158/1541-7786.MCR-04-0065
Keywords
-
Categories
Funding
- NCI NIH HHS [CA23074, P30 CA023074-30, CA27502, P01 CA027502-21] Funding Source: Medline
Ask authors/readers for more resources
Activation of activator protein-1 (AP-1) and increased expression of cyclooxygenase-2 (COX-2) have been clearly shown to play a functional role in UVB-induced skin tumor promotion. In this study, we examined UVB-induced signal transduction pathways in SKH-1 mouse epidermis leading to increases in COX-2 expression and AP-1 activity. We observed rapid increases in p38 mitogen-activated protein kinase (MAPK) signaling through activation of p38 MAPK and its downstream target, MAPK activated protein kinase-2. UVB also increased phosphatidylinositol 3-kinase (Pl3K) signaling as observed through increases in AKT and GSK-3beta phosphorylation. Activation of the p38 MAPK and Pl3K pathways results in the phosphorylation of cyclic AMP-responsive element binding protein, which was also observed in UVB-irradiated SKH-1 mice. Topical treatment with SB202190 (a specific inhibitor of p38 MAPK) or LY294002 (a specific inhibitor of Pl3K) significantly decreased UVB-induced AP-1 activation by 84% and 68%, respectively, as well as COX-2 expression. Our data show that in mouse epidermis, UVB activation of the p38 MAPK and Pl3K pathways leads to AP-1 activation and COX-2 expression.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available